SEATTLE, May 27, 2015 /PRNewswire/ — LumiThera Inc., a developmental stage medical device company creating a non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, announced today that they were awarded a Washington State Life Sciences Discovery Fund (LSDF) commercialization grant. LumiThera was 1 of 3 recipients of the LSDF matching grants worth $500,000 to… Continue reading
SEATTLE, May 6, 2015 /PRNewswire/ — LumiThera Inc., a medical device company focused on the development of non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, today announced Retired Congressman Norman Dicks has agreed to join LumiThera’s Advisory Board to assist in the company’s mission to treat vision impairment. Norman DeValois “Norm” Dicks was the… Continue reading
SEATTLE, June 9, 2014 /PRNewswire/ – LumiThera Inc., a medical device company focused on the development of non-invasive light emitting diode (LED) treatments for ocular disorders and disease, today announced Ret. Major General Gale Pollock has joined their Scientific Advisory Board. The first woman to serve as Acting Surgeon General of the United States Army… Continue reading
United Nations Headquarters (New York) presentation to the Global Health Impact Forum, 6th May 2014 by co founder James Carroll This 15 minute video starts with an overview of Photobiomodulation and low level light therapy as it relates to his company THOR Photomedicine. Later in the presentation James introduces Lumithera and our treatment for Age related… Continue reading
SEATTLE, April 28, 2014 /PRNewswire/ – LumiThera Inc., a medical device company focused on the development of non-invasive light emitting diode (LED) treatment for ocular disorders and disease, today announced it is a recipient of a Washington State Life Sciences Discovery Award (LSDF) grant. LumiThera was 1 of 5 recipients of the LSDF grants each… Continue reading
